Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v4-EN | Version v1-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2025-01-27 | 2023-03-30 |
| Drug Identification Number | 02487454 | 02487454 |
| Brand name | SKYRIZI | SKYRIZI |
| Common or Proper name | Risankizumab | Risankizumab |
| Company Name | ABBVIE CORPORATION | ABBVIE CORPORATION |
| Ingredients | RISANKIZUMAB | RISANKIZUMAB |
| Strength(s) | 90MG | 90MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging sizes (GTIN) | (See additional packaging sizes) | (See additional packaging sizes) |
| Additional packaging sizes | 2 x 75 mg/0.83 mL Syringe | 2 x 75 mg/0.83 mL Syringe |
| ATC code | L04AC | L04AC |
| ATC description | ||
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | 2023-09-01 | 2023-09-01 |
| Actual start date | 2023-09-01 | 2023-09-01 |
| Estimated end date | Unknown | Unknown |
| Actual end date | 2024-12-16 | |
| Shortage status | Resolved | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | SKYRIZI 75mg/0.83 mL (90 mg/mL) pre-filled syringe format is slowly being depleted and is no longer available to order. For several months now, SKYRIZI has been available in two other formats – a 150 mg/1 mL (150 mg/mL) pre-filled pen or a 150 mg/1 mL (150 mg/mL) syringe for order. The decision of discontinuation was made at the end of 2024. AbbVie no longer intends to be meeting demand and this drug will be discontinued. | SKYRIZI 75mg/0.83 mL (90 mg/mL) pre-filled syringe format is slowly being depleted and is no longer available to order. For several months now, SKYRIZI has been available in two other formats – a 150 mg/1 mL (150 mg/mL) pre-filled pen or a 150 mg/1 mL (150 mg/mL) syringe for order. |
| Health Canada comments |